Human Flt-3 Ligand/FLT3L Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB308
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human, Mouse, Primate - Papio cynocephalus (Yellow Baboon)
Applications
Validated:
Western Blot, Neutralization
Cited:
Neutralization, ELISA Development
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # 40406
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Flt‑3 Ligand/FLT3L
Thr27-Pro185
Accession # AAA17999
Thr27-Pro185
Accession # AAA17999
Specificity
Detects human Flt-3 Ligand/FLT3L in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant mouse Flt-3 Ligand/FLT3L is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Scientific Data Images for Human Flt-3 Ligand/FLT3L Antibody
Cell Proliferation Induced by Flt-3 Ligand/FLT3L and Neutralization by Human Flt-3 Ligand/FLT3L Antibody.
Recombinant Human Flt-3 Ligand/FLT3L (Catalog # 308-FK or 308-FKN) stimulates proliferation in the BaF3 mouse pro-B cell line transfected with mouse Flt-3 in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human Flt-3 Ligand/FLT3L (5 ng/mL) is neutralized (green line) by increasing concentrations of Human Flt-3 Ligand/FLT3L Monoclonal Antibody (Catalog # MAB308). The ND50 is typically 0.02-0.06 µg/mL.Detection of Flt-3 Ligand/FLT3L by Flow Cytometry
Expansion of human DC populations by Alb-Flt3L in humanized mice.NSG mice were irradiated and engrafted with human CD34+ cells according to Taconic’s established protocols. Successful chimerism was confirmed by flow cytometry. Three mice from each donor were generated, allowing for a donor-match control to be in each group (n = 3). Mice were administered Flt3L, Alb-Flt3L (equimolar amounts), or vehicle control every 5 days for a total of 3 doses. Mice were then euthanized, and spleens and bone marrow were harvested and used for immune cell analysis. Representative flow gating and percentages of total DCs gated as CD11c+HLA-DR+ (A and D), cDC1s gated as CD11c+HLA-DR+CD141+ (B and F), cDC2s gated as CD11c+HLA-DR+CD1c+ (B and G), and pDCs gated as CD11c+HLA-DRloCD123+CD303+ (C and E). Representative SPADE analysis of flow cytometry data collected from (H) spleen or (I) bone marrow of mice treated with vehicle, Flt3L, or Alb-Flt3L (equimolar amount). Donor-matched controls are shown. Vehicle was used to set baseline cell populations in each cluster. scRNA-seq data collected from donor-matched spleens of mice treated with vehicle or Alb-Flt3L. UMAP projection of scRNA-seq data from (J) vehicle-treated (naive) or (K) Alb-Flt3L–treated mice. Mono, monocytes. (L) Heatmap showing gene cluster differences in mice treated with Alb-Flt3L compared with control. *P < 0.05; **P < 0.01; ***P < 0.001 by 2-tailed Student’s t test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37917174), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human Flt-3 Ligand/FLT3L Antibody
Application
Recommended Usage
Western Blot
1 µg/mL
Sample: Recombinant Human Flt‑3 Ligand/FLT3L (Catalog # 308-FK) under non-reducing conditions only.
Sample: Recombinant Human Flt‑3 Ligand/FLT3L (Catalog # 308-FK) under non-reducing conditions only.
Neutralization
Measured by its ability to neutralize Flt‑3 Ligand/FLT3L-induced proliferation in the BaF3 mouse pro‑B cell line transfected with mouse Flt‑3. Hannum, C. et al. (1994) Nature 368:643. The Neutralization Dose (ND50) is typically 0.02‑0.06 µg/mL in the presence of 5 ng/mL Recombinant Human Flt‑3 Ligand/FLT3L.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from ascites
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Flt-3 Ligand/FLT3L
Long Name
fms-like Tyrosine Kinase 3 Ligand
Alternate Names
FLG3L, Flt3L, FLT3LG
Gene Symbol
FLT3LG
UniProt
Additional Flt-3 Ligand/FLT3L Products
Product Documents for Human Flt-3 Ligand/FLT3L Antibody
Product Specific Notices for Human Flt-3 Ligand/FLT3L Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...